{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:08:48Z","timestamp":1791328128569,"version":"4.3.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vaccine.2008.10.076","type":"journal-article","created":{"date-parts":[[2008,11,15]],"date-time":"2008-11-15T09:47:22Z","timestamp":1226742442000},"page":"588-591","source":"Crossref","is-referenced-by-count":27,"title":["Does yellow fever 17D vaccine protect against melanoma?"],"prefix":"10.1016","volume":"27","author":[{"given":"G.","family":"Mastrangelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Krone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Buja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rausa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.F.","family":"Koelmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.10.076_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4065\/82.3.364","article-title":"Malignant melanoma in the 21st century. Part 1. Epidemiology, risk factors, screening, prevention, and diagnosis","volume":"82","author":"Markovic","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.vaccine.2008.10.076_bib2","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/S0959-8049(03)00625-7","article-title":"Impact of vaccinations and infectious diseases on melanoma risk\u2014evaluation of an EORTC case-control-study","volume":"39","author":"Krone","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.vaccine.2008.10.076_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00008390-199910000-00011","article-title":"Infections and melanoma risk: results of a multicentric EORTC case-control-study","volume":"9","author":"K\u00f6lmel","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1016\/j.vaccine.2008.10.076_bib4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1523-1747.2002.00643.x","article-title":"Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study","volume":"119","author":"Pfahlberg","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.vaccine.2008.10.076_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejca.2004.09.023","article-title":"Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with a better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients","volume":"41","author":"K\u00f6lmel","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.vaccine.2008.10.076_bib6","first-page":"5510","article-title":"A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes","volume":"62","author":"Schiavetti","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2008.10.076_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejca.2004.08.010","article-title":"Protection against melanoma by vaccination with Bacille Calmette-Gu\u00e9rin (BCG) and\/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control","volume":"41","author":"Krone","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.vaccine.2008.10.076_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1017921110363","article-title":"The characterization and purification of a human transcription factor modulating the glutathione peroxidase gene in response to oxygen tension","volume":"229","author":"Merante","year":"2002","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.vaccine.2008.10.076_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0099-9598(03)60006-4","article-title":"Chemical and biological aspects of melanin","volume":"60","author":"Chakraborty","year":"2003","journal-title":"Alkaloids Chem Biol"},{"key":"10.1016\/j.vaccine.2008.10.076_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","article-title":"Cancer immunoediting from immune surveillance to immune escape","volume":"121","author":"Kim","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2008.10.076_bib11","unstructured":"Saenz AC. Yellow fever vaccines: achievements, problems, needs. In: Proceedings of the International Conference on the Application of Vaccines against Viral, Rickettsial, and Bacterial Diseases of Man. Section A. Arbovirus Diseases (Sci Pub No 226). Washington, DC: Pan-American Health Organization; 1971. p. 31."},{"key":"10.1016\/j.vaccine.2008.10.076_bib12","first-page":"297","article-title":"Benefit versus risk factors in immunization against yellow fever","volume":"43","author":"Br\u00e8s","year":"1979","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2008.10.076_bib13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","author":"Martin","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2008.10.076_bib14","series-title":"Vaccines","first-page":"1095","article-title":"Yellow fever vaccine","author":"Monath","year":"2004"},{"key":"10.1016\/j.vaccine.2008.10.076_bib15","series-title":"Vaccines","first-page":"123","article-title":"Smallpox and vaccinia","author":"Henderson","year":"2004"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T09:56:51Z","timestamp":1545645411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08014898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0264410X08014898"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.10.076","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}